Roche Holding AG

RO.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RO.SW stands at 208.30B. In comparison, LLY.SW has a market cap of 763.13B. Regarding current trading prices, RO.SW is priced at $277.40, while LLY.SW trades at $805.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RO.SW currently has a P/E ratio of 26.93, whereas LLY.SW's P/E ratio is 79.47. In terms of profitability, RO.SW's ROE is +0.27%, compared to LLY.SW's ROE of +0.77%. Regarding short-term risk, RO.SW is more volatile compared to LLY.SW. This indicates potentially higher risk in terms of short-term price fluctuations for RO.SW.

RO.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RO.SW stands at 208.30B. In comparison, ROG.SW has a market cap of 211.77B. Regarding current trading prices, RO.SW is priced at $277.40, while ROG.SW trades at $261.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RO.SW currently has a P/E ratio of 26.93, whereas ROG.SW's P/E ratio is 25.43. In terms of profitability, RO.SW's ROE is +0.27%, compared to ROG.SW's ROE of +0.27%. Regarding short-term risk, RO.SW is less volatile compared to ROG.SW. This indicates potentially lower risk in terms of short-term price fluctuations for RO.SW.

RO.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RO.SW stands at 208.30B. In comparison, NOVN.SW has a market cap of 173.97B. Regarding current trading prices, RO.SW is priced at $277.40, while NOVN.SW trades at $91.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RO.SW currently has a P/E ratio of 26.93, whereas NOVN.SW's P/E ratio is 17.50. In terms of profitability, RO.SW's ROE is +0.27%, compared to NOVN.SW's ROE of +0.31%. Regarding short-term risk, RO.SW is more volatile compared to NOVN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for RO.SW.

RO.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RO.SW stands at 208.30B. In comparison, GSK.SW has a market cap of 101.55B. Regarding current trading prices, RO.SW is priced at $277.40, while GSK.SW trades at $19.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RO.SW currently has a P/E ratio of 26.93, whereas GSK.SW's P/E ratio is 18.76. In terms of profitability, RO.SW's ROE is +0.27%, compared to GSK.SW's ROE of +0.38%. Regarding short-term risk, Volatility data is not available for a full comparison. RO.SW has daily volatility of 5.03 and GSK.SW has daily volatility of N/A.

RO.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RO.SW stands at 208.30B. In comparison, BAYN.SW has a market cap of 66.80B. Regarding current trading prices, RO.SW is priced at $277.40, while BAYN.SW trades at $67.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RO.SW currently has a P/E ratio of 26.93, whereas BAYN.SW's P/E ratio is 14.34. In terms of profitability, RO.SW's ROE is +0.27%, compared to BAYN.SW's ROE of -0.03%. Regarding short-term risk, RO.SW is more volatile compared to BAYN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for RO.SW.

RO.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RO.SW stands at 208.30B. In comparison, COPN.SW has a market cap of 810.36M. Regarding current trading prices, RO.SW is priced at $277.40, while COPN.SW trades at $50.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RO.SW currently has a P/E ratio of 26.93, whereas COPN.SW's P/E ratio is 6.70. In terms of profitability, RO.SW's ROE is +0.27%, compared to COPN.SW's ROE of +0.14%. Regarding short-term risk, RO.SW is more volatile compared to COPN.SW. This indicates potentially higher risk in terms of short-term price fluctuations for RO.SW.